|
| [January 18, 2013] |
 |
Research and Markets: Delving into Stem Cell Research and its Potential in 2013
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/whz9kz/delving_into_stem)
has announced the addition of the "Delving
into Stem Cell Research and its Potential" report to their
offering.
Stem cells are primal cells found in all multi-cellular organisms that
retain the ability to renew themselves through mitotic cell division and
can differentiate into a wide range of specialized cell types.
As stem cells can be readily grown and transformed into specialized
cells with characteristics consistent with cells of various tissues such
as muscles or nerves through cell culture, their use in medical
therapies has been proposed. In particular, embryonic cell lines,
autologous embryonic stem cells generated through therapeutic cloning,
and highly plastic adult stem cells from the umbilical cord blood or
one marrow are touted as promising candidates.
There exists a widespread controversy over stem cell research that
emanates from the techniques used in the creation and usage of stem
cells. Human embryonic stem cell research is particularly controversial
because, with the present state of technology, starting a stem cell line
requires the destruction of a human embryo and/or therapeutic cloning.
Challenges, barriers, benefits of stem cells, a look at the global
approach to stem cell research, and an analysis of the leading players
in this industry are what make this report a must-have!
Key Topics Covered:
A. Executive Summary
B. Introduction to Stem Cells
C. Looking into Stem Cell Research
D. Potential of Stem Cell Research & Therapies
E. Benefits of Stem Cell Therapies
F. Barriers & Challenges in Stem Cell Research
G. Stem Cell in Medical Use
H. Trends in the Industry
I. Funding for Stem Cell Research
J. Global Approach to Human Stem Cell Research
K. Industry Outlook
L. Leading Players in Stem Cell Research
M. Appendix
N. Glossary of Terms
Companies Mentioned
-
Aastrom Biosciences
-
Amgen
-
Geron Corporation
-
Advanced Cell Technology
-
Cryo-Cell International
-
Celera Corporation
-
Biomagnetics Diagnostics Corporation
-
CytoGenix, Inc.
-
Transition Therapeutics Inc.
-
ThermoGenesis Corporation
-
Cytori Therapeutics Inc
-
StemCells Inc
-
Osiris Therapeutics, Inc.
For more information visit http://www.researchandmarkets.com/research/whz9kz/delving_into_stem

[ Back To Technology News's Homepage ]
|